PUBLISHER: The Business Research Company | PRODUCT CODE: 1877778
PUBLISHER: The Business Research Company | PRODUCT CODE: 1877778
A home spirometry app is a digital tool designed to measure and monitor lung function remotely. It connects with spirometry devices to capture detailed respiratory metrics such as forced expiratory volume, forced vital capacity, and peak expiratory flow, providing accurate data on lung performance. The app securely stores, organizes, and visualizes respiratory data over time, allowing trends and patterns to be analyzed to support continuous monitoring, early detection of changes, and management of pulmonary health.
The primary product types of home spirometry apps are standalone apps and integrated apps. A standalone app is a self-sufficient software application that operates independently on a device without requiring external systems or internet connectivity for its core functions. These apps are available across various platforms such as iOS, Android, Windows, and others, and are distributed through app stores, direct sales, healthcare facilities, and other channels. They are used for conditions including chronic obstructive pulmonary disease, asthma, cystic fibrosis, pulmonary fibrosis, and other respiratory disorders, and are utilized by patients, healthcare providers, and research institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The home spirometry app market research report is one of a series of new reports from The Business Research Company that provides home spirometry app market statistics, including home spirometry app industry global market size, regional shares, competitors with the home spirometry app market share, home spirometry app market segments, market trends, and opportunities, and any further data you may need to thrive in the home spirometry app industry. This home spirometry app market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The home spirometry app market size has grown rapidly in recent years. It will grow from $0.97 billion in 2024 to $1.13 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, adoption of remote patient monitoring, rise in chronic respiratory conditions, growing demand for home healthcare solutions, expansion of home-based healthcare services, and the rise of digital therapeutics.
The home spirometry app market size is expected to see rapid growth in the next few years. It will grow to $2.04 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth during the forecast period can be attributed to the expansion of telemedicine services, increasing healthcare expenditure, rising awareness of respiratory health, focus on patient-centric care models, and growth in wearable health technology. Key trends in the forecast period include technological advancements in mobile health, developments in artificial intelligence and machine learning, enhancements in mobile app functionalities, a shift towards integrated spirometry solutions, and growth in collaborations between technology companies and healthcare providers.
The rising prevalence of respiratory diseases is expected to drive the growth of the home spirometry app market. Respiratory diseases are medical conditions that affect the lungs and airways, causing difficulty in breathing and symptoms such as coughing, wheezing, shortness of breath, and chest discomfort. The prevalence of these diseases is increasing due to the aging population, which is more prone to chronic lung conditions, and higher exposure to air pollution that worsens respiratory health. Home spirometry apps support disease management by allowing patients to monitor lung function regularly from home, track symptoms over time, detect early signs of deterioration, and share real-time data with healthcare providers for timely intervention, helping maintain better respiratory health and prevent complications. For example, in October 2024, the National Asthma Council of Australia reported 474 asthma-related deaths in 2023, comprising 325 females and 149 males, almost identical to the 473 deaths reported in 2022, indicating a consistent trend in asthma mortality. This highlights how the increasing prevalence of respiratory diseases is fueling the home spirometry app market.
Key companies in the home spirometry app market are focusing on developing innovative products such as cardiopulmonary assessment devices to enable remote monitoring, enhance disease management, and personalize treatment for respiratory patients. Cardiopulmonary assessment devices help patients and clinicians track heart and lung function in real time, facilitating early detection of respiratory issues, personalized treatment adjustments, and improved management of chronic conditions such as asthma and COPD. For instance, in September 2025, electronRx Ltd., a UK-based deep tech company, launched the pDx app, a home-based cardiopulmonary assessment platform for patients with chronic respiratory diseases. The app allows users to measure lung function using smartphones, tablets, or laptops while generating digital biomarkers including heart rate, respiratory rate, and tidal volume. Clinicians can access real-time data through a secure dashboard, enabling remote monitoring, early detection of disease progression, and personalized treatment adjustments, reducing hospital visits and improving patient outcomes. The platform also integrates tailored questionnaires and provides detailed results to both patients and healthcare providers, supporting informed decision-making and enhancing patient engagement in their care.
In May 2025, Huma Therapeutics Limited, a UK-based health technology company, acquired Aluna, Inc. for an undisclosed amount. This acquisition allows Huma to expand its respiratory health capabilities by integrating Aluna's AI-powered remote monitoring solutions and proprietary spirometers into the Huma Cloud Platform, creating a comprehensive digital health ecosystem that enhances chronic respiratory care for patients, providers, and health systems worldwide. Aluna Inc., based in the US, specializes in providing a home spirometry application for remote respiratory health monitoring.
Major players in the home spirometry app market are Cipla Limited, Clario Inc., Contec Medical Systems Co. Ltd., Vitalograph Ltd., NDD Medical Technologies AG, CareSimple Inc., MediTuner AB, NuvoAir AB, Monitored Therapeutics Inc., Sibelmed S.A., ZEPHYRx LLC, Alveofit Technologies Pvt. Ltd., Spiromagic ApS, Respirit Healthcare Pvt. Ltd., patientMpower Ltd., CMI Health Inc. (SpiroLink), Smart Respiratory Products Ltd., Koneksa Health Inc., AioCare Sp. z o.o., VitalFlo Inc.
North America was the largest region in the home spirometry app market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in home spirometry app report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the home spirometry app market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The home spirometry app market consists of revenues earned by entities by providing services such as telehealth integration, personalized health coaching, data storage and trend tracking, software development kits (SDKs) medication adherence tracking, patient education and training, clinical trial support, predictive analytics, multi-device connectivity, insurance and reimbursement support, professional dashboards for healthcare providers, and regulatory compliance and data security services. The market value includes the value of related goods sold by the service provider or included within the service offering. The home spirometry app market also includes sales of accessories and supporting tools, digital home spirometers, remote monitoring and telehealth platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Home Spirometry App Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on home spirometry app market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for home spirometry app ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The home spirometry app market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.